Humana Inc.
03/02/2026 | Press release | Distributed by Public on 03/02/2026 06:30
Regulation FD Disclosure (Form 8-K)
Item 7.01. Regulation FD Disclosure.
Members of Humana Inc.'s (the "Company") senior management team are scheduled to meet with investors and analysts at various meetings between March 2, 2026 and March 31, 2026. During these meetings, the Company intends to reaffirm its guidance of at least $8.89 in diluted earnings per common share ("EPS") or at least $9.00 in adjusted earnings per common share ("Adjusted EPS"), in each case for the year ending December 31, 2026 ("FY 2026"). This guidance is consistent with the guidance issued in Humana's press release dated February 11, 2026.
The Company has included Adjusted (non-GAAP) EPS in this current report, a financial measure that is not in accordance with Generally Accepted Accounting Principles ("GAAP"). Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, provides a comprehensive perspective to more accurately compare and analyze the Company's core operating performance over time. Consequently, management uses Adjusted (non-GAAP) EPS as a consistent indicator of the Company's core business operations from period to period, as well as for planning and decision-making purposes and in determination of incentive compensation. Adjusted (non-GAAP) EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. Adjusted (non-GAAP) EPS is subject to inherent limitations and may differ from the similarly titled measure used by other companies. A reconciliation of GAAP EPS to Adjusted (non-GAAP) EPS follows:
| Diluted earnings per share | FY 2026 Guidance | ||||
| GAAP | at least $8.89 | ||||
| Amortization of identifiable intangibles | 0.15 | ||||
| Cumulative net tax impact | (0.04) | ||||
| Adjusted (non-GAAP) - FY 2026 projected | at least $9.00 | ||||
(a)FY 2026 GAAP EPS guidance and FY 2026 Adjusted (non-GAAP) EPS guidance exclude the impact of future value changes to items that have not yet been recognized or cannot currently be reasonably estimated. The Company does not expect changes to its FY 2026 Adjusted (non-GAAP) EPS guidance. The Company does expect potential changes to its FY 2026 GAAP EPS guidance due to its ongoing value creation and other strategic initiatives.
Humana Inc. published this content on March 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on March 02, 2026 at 12:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]